, Tracking Stock Market Picks
Enter Symbol:
Rating: ORPN
Buy $25
down 11.00 %

Bio Blast Pharma Ltd. (NASDAQ: ORPN) reiterated to Buy with price target $25 by Roth Capital

Monday,  Jun 15, 2015  10:25 AM ET by Kristen Bailey

The Roth Capital advised against investing in this stock and the price has fallen for a loss. The price fell from $7.20 on 01/08/2015 to $6.40 on 06/15/2015. Roth Capital reiterated Bio Blast
Pharma Ltd. (NASDAQ: ORPN) to Buy with price target $25 with today's price of $6.40. Roth Capital rated Bio Blast Pharma Ltd. (NASDAQ: ORPN) to Buy with price target $18 on 01/08/2015, when the price was $7.20. Bio Blast Pharma Ltd.'s stock price lost 11% since then.
By following the previous Roth Capital's recommendation on ORPN, you would have lost 11% in 158 days.

ROTH researches emerging growth equities in the media, technology, telecommunications, healthcare, consumer, energy and industrial sectors. The research is focused on companies with market capitalization of between $100 million - $1 billion. Our coverage universe includes approximately 180 small cap growth companies around the globe including several companies from China. With an average market cap of approximately $500 million, our objective is to identify rapidly growing companies with significant long term growth prospects.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy